Podcast | Executive Insights on Accelerating Drug Development and Market Access in Japan & Asia-Pacific
A RAPS Podcast Recorded Live at JP Morgan Healthcare Conference 2026
Featuring Keiko Oishi, President & COO, CMIC Group
Recorded during the JP Morgan Healthcare Conference 2026 in collaboration with the Regulatory Affairs Professionals Society (RAPS), this exclusive podcast features Keiko Oishi, President and COO of CMIC Group, sharing strategic insights on the future of drug development, regulatory reform, and market access in Japan and the Asia-Pacific region.
As Japan continues to address long-standing challenges such as drug lag and drug loss, global pharma and biotech leaders are re-evaluating how—and when—to include Japan and APAC in their development strategies. In this timely conversation, Mrs. Oishi explains how policy shifts, regulatory flexibility, and regional convergence are reshaping global development timelines.
What you’ll learn in this podcast:
-
How Japan’s regulatory environment is evolving through 2026
-
Why Japan and South Korea are becoming strategic extensions of Western development programs
-
The value of a fully integrated service model
-
Key cultural, regulatory, and operational considerations
-
Long-term opportunities and challenges in Asia-Pacific
Who should listen and download:
-
Pharma and biotech executives planning global or Asia-inclusive clinical trials
-
Companies evaluating Japan market entry or expansion
-
Clinical development, regulatory, and strategy leaders seeking faster, lower-risk pathways in APAC
👉 Download the podcast to gain actionable insights shaping Japan and Asia-Pacific drug development strategies in 2026 and beyond.
